SCHEMBL658478

SCHEMBL658478

CC(C)(C)Sc1c(Br)cncc1C=NO

nearest known ligand 0.31

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ALOX12 P18054 1/20 0.31
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658477 1.00 MEN1 (0.31) MEN1ALDH1A1KMT2AL3MBTL1ALOX12
SCHEMBL658741 0.79 PRKDC (0.33)
SCHEMBL660820 0.76 ALOX12 (0.45) MEN1ALDH1A1KMT2AL3MBTL1ALOX12
SCHEMBL660821 0.76 ALOX12 (0.45) MEN1ALDH1A1KMT2AL3MBTL1ALOX12
SCHEMBL659017 0.74 ALDH1A1 (0.33) MEN1ALDH1A1KMT2AL3MBTL1ALOX12
SCHEMBL659016 0.74 ALDH1A1 (0.33) MEN1ALDH1A1KMT2AL3MBTL1ALOX12
SCHEMBL28168693 0.72 MAPT (0.34) MEN1ALDH1A1KMT2AL3MBTL1ALOX12
SCHEMBL30127063 0.71 ALDH1A1 (0.33) MEN1ALDH1A1KMT2AL3MBTL1ALOX12
SCHEMBL659677 0.70 KMT2A (0.44) MEN1ALDH1A1KMT2AL3MBTL1MAPT
SCHEMBL659676 0.70 KMT2A (0.44) MEN1ALDH1A1KMT2AL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250049035-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2025-02-13 US disclosed
EP-4448534-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES Syngenta Crop Protection AG (CH) 2024-10-23 EP disclosed
CN-118339167-A Microbiocidal bicyclic heterocyclic derivatives 先正达农作物保护股份公司 2024-07-12 CN disclosed
WO-2023110869-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2023-06-22 WO disclosed
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250049035-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES NOX1, CASP1, CYP1A1 MEN1 3301/4885ALDH1A1 954/4885KMT2A 4317/4885
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 MEN1 296/4885ALDH1A1 490/4885KMT2A 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.